Skip to search formSkip to main contentSkip to account menu

pentaformylgitoxin

Known as: gitoformate, formiloxin, 3 beta,14 beta- dihydroxy-16 beta-formyloxy-5 beta-card-20(22)- enolide 3-tetraformyltridigitoxoside 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Digoxin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
[Postprandial delay of drug absorption in a gitoformate model].
Oral absorption of gitoformate (Dynocard), a non-renal-dependent cardiac glycoside, was investigated in 8 healthy subjects aged… 
1984
1984
[Plasma levels of gitoxin (by RIA and rubidium-86 uptake) and systolic time after treatment with a single dose of gitoformate].
1981
1981
[Pharmacokinetics and pharmacodynamics of gitoformate in subjects with atrial fibrillation].
1981
1981
[Pharmacokinetics of gitoformate in subjects with renal insufficiency under dialysis treatment].
1980
1980
Pharmacokinetic Study of Gitoformate in Renal-insufficiency
1980
1980
Pharmacokinetic Study of Gitoformate in Healthy-volunteers
1979
1979
[Effect of renal insufficiency on the pharmacokinetic parameters of gitoformate in man].
1979
1979
[Gitoformate in chronic renal insufficiency: pharmacokinetic aspects].
1978
1978
[Pharmacokinetic and biopharmaceutic parameters of gitoformate].
1966
1966
Cardiotonic properties of formiloxin a semi-synthetic cardiac glycoside.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)